Central Nervous System Pharmacology Practice Questions

Q: Which drug is used to prevent alcohol withdrawal syndrome?

Diazepam. **Explanation:** **1. Why Diazepam is the Correct Answer:** Benzodiazepines (BZDs) like **Diazepam** are the **gold standard and first-line treatment** for preventing and managing Alcohol Withdrawal Syndrome (AWS). Chronic alcohol consumption causes down-regulation of GABA receptors and up-regulation of NMDA receptors. Sudden cessation leads to a state of CNS hyperexcitability. Diazepam, a long-acting BZD, acts as a GABA-A agonist, providing **cross-tolerance** with alcohol. It effectively prevents seizures, delirium tremens, and stabilizes vital signs due to its long half-life and active metabolites. **2. Why Other Options are Incorrect:** * **Clonidine (B):** An alpha-2 agonist that helps reduce autonomic overactivity (tachycardia, hypertension) but **does not prevent seizures or delirium**, which are the most dangerous complications of withdrawal. * **Propranolol (C):** A beta-blocker used symptomatically to control tremors and tachycardia. Like clonidine, it lacks anti-epileptic properties and can mask the early signs of withdrawal. * **Methadone (D):** A mu-opioid receptor agonist used specifically for **Opioid withdrawal** and maintenance therapy, not for alcohol withdrawal. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Chlordiazepoxide or Diazepam are preferred due to their long half-life (self-tapering effect). * **Liver Failure Exception:** In patients with cirrhosis or liver failure, use **LOT** drugs (**L**orazepam, **O**xazepam, **T**emazepam) as they do not require hepatic oxidation and have no active metabolites. * **Wernicke’s Encephalopathy:** Always administer **Thiamine (B1)** before glucose to prevent precipitating Wernicke’s. * **Disulfiram:** Used for aversion therapy (maintenance of abstinence), never for acute withdrawal.

Q: Which local anesthetic is commonly used in wound or ulcer management?

Benzocaine. **Explanation:** **Benzocaine** is the correct answer because it is a unique ester-linked local anesthetic characterized by its **very low solubility in water**. Due to this property, it is absorbed too slowly to be given by injection but is highly effective for **topical application** on mucous membranes and denuded skin surfaces (wounds or ulcers). It provides prolonged surface anesthesia without significant systemic toxicity, making it the drug of choice for treating painful skin conditions, mouth ulcers, and as a throat spray before endoscopy. **Analysis of Incorrect Options:** * **Prilocaine (A):** An amide local anesthetic primarily used for infiltration and regional blocks. It is a component of EMLA cream but is not used alone for open wound management. Its major side effect is methemoglobinemia. * **Chloroprocaine (B):** An ester anesthetic with a very short duration of action due to rapid hydrolysis by plasma cholinesterase. It is primarily used for infiltration and epidural anesthesia, not topical wound care. * **Bupivacaine (D):** A potent, long-acting amide anesthetic. It is highly cardiotoxic if absorbed systemically and is used for infiltration, spinal, and epidural anesthesia, but lacks effective topical activity on intact skin or ulcers. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Benzocaine acts by blocking voltage-gated sodium channels, but unlike others, it exists almost entirely in the **unionized form** at physiological pH. * **Side Effect:** Like prilocaine, benzocaine can cause **methemoglobinemia** if used in excessive quantities topically. * **EMLA Cream:** A eutectic mixture of **Lidocaine (2.5%) and Prilocaine (2.5%)** used to anesthetize intact skin before venipuncture. * **Cocaine:** The only local anesthetic with intrinsic **vasoconstrictive** properties; all others are vasodilators (except ropivacaine/levobupivacaine which have mild vasoconstriction).

Q: Spina bifida is a known complication associated with the use of which medication?

Carbamazepine. **Explanation:** The correct answer is **Carbamazepine**. **1. Why Carbamazepine is Correct:** Carbamazepine is a classic enzyme-inducing anticonvulsant. It is a known human teratogen associated with a 1% risk of **Neural Tube Defects (NTDs)**, specifically **Spina Bifida**. The underlying mechanism involves the drug’s interference with **folate metabolism** and the production of reactive epoxide metabolites. When taken during the first trimester (the period of organogenesis), it inhibits the proper closure of the neural tube. **2. Why the Other Options are Incorrect:** * **Clozapine & Olanzapine:** These are atypical antipsychotics. They are generally not associated with structural malformations like Spina Bifida. Their primary concern in pregnancy is metabolic (e.g., gestational diabetes and excessive weight gain). * **Lithium:** This mood stabilizer is classically associated with **Ebstein’s Anomaly**, a congenital cardiac defect involving the tricuspid valve, rather than neural tube defects. **3. High-Yield Clinical Pearls for NEET-PG:** * **Valproate vs. Carbamazepine:** While both cause Spina Bifida, **Sodium Valproate** carries the highest risk (approx. 2-5%) and is the most common cause of drug-induced NTDs. * **Prevention:** To reduce the risk of NTDs in women taking antiepileptic drugs (AEDs), high-dose **Folic Acid (4-5 mg/day)** supplementation is recommended starting before conception. * **Fetal Hydantoin Syndrome:** Associated with **Phenytoin**, characterized by craniofacial anomalies, hypoplastic nails, and phalanges. * **Safe AEDs in Pregnancy:** Levetiracetam and Lamotrigine are currently considered to have the lowest teratogenic potential.

Q: A teenager presents with persistent and severe headaches. The physician diagnoses migraine and prescribes sumatriptan. By which of the following mechanisms does sumatriptan act?

Serotonin 1D agonist. **Explanation:** **Mechanism of Action (Correct Option):** Sumatriptan is a selective **5-HT$_{1B/1D}$ receptor agonist**. It is the prototype of the "Triptan" class used for the acute management of migraine. Its therapeutic effect is mediated via three primary mechanisms: 1. **Vasoconstriction:** Activation of 5-HT$_{1B}$ receptors on intracranial blood vessels leads to the constriction of painfully dilated meningeal vessels. 2. **Inhibition of Neuropeptides:** Activation of 5-HT$_{1D}$ receptors on trigeminal nerve terminals inhibits the release of pro-inflammatory neuropeptides (e.g., Calcitonin Gene-Related Peptide or CGRP and Substance P). 3. **Central Inhibition:** It reduces the transmission of pain signals through the trigeminal nucleus caudalis. **Analysis of Incorrect Options:** * **Option A (D1 Agonist):** Dopamine agonists (like Fenoldopam) are used in hypertensive emergencies or Parkinson’s disease. In migraine, dopamine *antagonists* (e.g., Metoclopramide) are used as adjuncts to treat nausea and enhance gastric emptying. * **Option B (GABA$_B$ Antagonist):** GABA$_B$ agonists (like Baclofen) are muscle relaxants. Antagonists have no established role in migraine therapy. * **Option C (M3 Antagonist):** These drugs (e.g., Oxybutynin) are used for overactive bladder or COPD. Anticholinergics are not indicated for migraine. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Triptans are the DOC for **acute severe migraine** attacks but are *not* used for prophylaxis. * **Contraindications:** Due to their vasoconstrictive properties, they are strictly contraindicated in patients with **Ischemic Heart Disease (Prinzmetal angina/MI)**, uncontrolled hypertension, and peripheral vascular disease. * **Serotonin Syndrome:** Caution is required when co-administered with SSRIs or MAO inhibitors.

Q: Which of the following drugs is NOT used in the management of Alzheimer's disease?

Clonidine. **Explanation:** The management of Alzheimer’s Disease (AD) primarily focuses on enhancing cholinergic transmission or modulating glutamatergic excitability. **Clonidine** is the correct answer because it is a **centrally acting alpha-2 ($\alpha_2$) adrenergic agonist** used primarily for hypertension, ADHD, and opioid withdrawal; it has no role in treating the cognitive decline of Alzheimer’s. **Analysis of Options:** * **Rivastigmine & Donepezil (Options A & C):** These are **Centrally acting Reversible Acetylcholinesterase Inhibitors (AChEIs)**. Alzheimer’s is characterized by a deficiency of acetylcholine in the nucleus basalis of Meynert. These drugs increase synaptic acetylcholine levels, improving cognitive function in mild-to-moderate AD. *Note: Rivastigmine is unique as it inhibits both AChE and Butyrylcholinesterase.* * **Memantine (Option B):** This is an **NMDA receptor antagonist**. It prevents glutamate-induced excitotoxicity, which leads to neuronal death in AD. It is typically used for moderate-to-severe cases, often in combination with Donepezil. **High-Yield Clinical Pearls for NEET-PG:** 1. **Donepezil** is the most commonly used AChEI due to its once-daily dosing and better tolerability. 2. **Galantamine** is another AChEI used in AD that also acts as a nicotinic receptor modulator. 3. **Side Effects of AChEIs:** Primarily GI-related (nausea, diarrhea) and bradycardia (SLUDGE effects). 4. **Newer Drugs:** **Aducanumab** and **Lecanemab** (monoclonal antibodies against amyloid-beta plaques) are recent FDA-approved disease-modifying therapies. 5. **Clonidine Side Effects:** Sedation, dry mouth (xerostomia), and rebound hypertension if stopped abruptly.

Q: Which Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) is used to treat pain associated with diabetic neuropathy?

Duloxetine. **Explanation:** **Duloxetine** is a potent Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) that is FDA-approved for the management of chronic pain conditions, specifically **diabetic peripheral neuropathic pain (DPNP)**, fibromyalgia, and chronic musculoskeletal pain. Its efficacy stems from its ability to enhance descending inhibitory pain pathways in the spinal cord by increasing the synaptic concentration of both serotonin and norepinephrine. **Analysis of Options:** * **Duloxetine (Correct):** It is the first-line SNRI for diabetic neuropathy. It has a balanced inhibition of both reuptake transporters and is preferred due to extensive clinical evidence for neuropathic pain. * **Clomipramine:** This is a Tricyclic Antidepressant (TCA). While TCAs are used off-label for neuropathy, Clomipramine is primarily used for Obsessive-Compulsive Disorder (OCD) and is not an SNRI. * **Venlafaxine:** Although it is an SNRI used off-label for neuropathic pain, it is not the primary choice or the specific answer sought for "approved" indications in this context. At lower doses, it acts primarily as an SSRI; its norepinephrine effect only becomes significant at higher doses. * **Desvenlafaxine:** The active metabolite of venlafaxine. While it is an SNRI, it is primarily indicated for Major Depressive Disorder and lacks the robust clinical labeling for diabetic neuropathy that duloxetine possesses. **High-Yield Pearls for NEET-PG:** * **First-line drugs for Diabetic Neuropathy:** Duloxetine (SNRI), Pregabalin/Gabapentin (Calcium channel α2-δ ligands), and Amitriptyline (TCA). * **Duloxetine Side Effects:** Nausea (most common), dry mouth, and somnolence. It should be avoided in patients with chronic liver disease. * **Mechanism:** SNRIs treat pain by increasing norepinephrine in the **descending antinociceptive pathway**, which inhibits the transmission of pain signals from the periphery to the brain.

Q: Which of the following anti-Parkinson drugs can lead to the adverse effect described?

Amantadine. ***Amantadine*** - Causes **livedo reticularis** (net-like, mottled purplish skin discoloration) due to its **anticholinergic properties** and effects on peripheral blood flow. - This distinctive **dermatological adverse effect** occurs in up to 90% of patients on long-term amantadine therapy and is reversible upon discontinuation. *Ropinirole* - A **dopamine agonist** that primarily causes **nausea, orthostatic hypotension**, and **impulse control disorders** like gambling. - Does not cause **livedo reticularis** as it lacks the anticholinergic and vascular effects seen with amantadine. *Tolcapone* - A **COMT inhibitor** that can cause severe **hepatotoxicity** requiring regular liver function monitoring. - Main adverse effects include **dyskinesia, nausea**, and **orange discoloration of urine**, not skin mottling. *Selegiline* - A **MAO-B inhibitor** that can cause **insomnia, orthostatic hypotension**, and **serotonin syndrome** when combined with certain antidepressants. - Does not affect **peripheral circulation** or cause the characteristic skin changes associated with amantadine.

Question 1

An acute syndrome of abnormal involuntary movements resembling tardive dyskinesia is associated with excessive dosage of which of the following medications?

Accepted Answer

Reserpine

Answer

Propranolol

Answer

Clonidine

Answer

Levodopa

Question 2

Which drug is used to prevent alcohol withdrawal syndrome?

Accepted Answer

Diazepam

Answer

Clonidine

Answer

Propranolol

Answer

Methadone

Question 3

Which local anesthetic is commonly used in wound or ulcer management?

Accepted Answer

Benzocaine

Answer

Prilocaine

Answer

Chloroprocaine

Answer

Bupivacaine

Question 4

Which of the following is not a side effect of phenytoin?

Accepted Answer

Hypoglycemia

Answer

Osteomalacia

Answer

Gum hypertrophy

Answer

Lymphadenopathy

Question 5

Which of the following conditions makes the nerve membrane more susceptible to the action of local anesthetics?

Accepted Answer

Increased extracellular potassium

Answer

Increased extracellular calcium

Answer

Increased extracellular sodium

Answer

Decreased extracellular chloride

Question 6

Spina bifida is a known complication associated with the use of which medication?

Accepted Answer

Carbamazepine

Answer

Clozapine

Answer

Lithium

Answer

Olanzapine

Question 7

A teenager presents with persistent and severe headaches. The physician diagnoses migraine and prescribes sumatriptan. By which of the following mechanisms does sumatriptan act?

Accepted Answer

Serotonin 1D agonist

Answer

Dopamine 1 agonist

Answer

GABAB antagonist

Answer

Muscarinic 3 antagonist

Question 8

Which of the following drugs is NOT used in the management of Alzheimer's disease?

Accepted Answer

Clonidine

Answer

Rivastigmine

Answer

Memantine

Answer

Donepezil

Question 9

Which Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) is used to treat pain associated with diabetic neuropathy?

Accepted Answer

Duloxetine

Answer

Clomipramine

Answer

Venlafaxine

Answer

Desvenlafaxine

Question 10

Which of the following anti-Parkinson drugs can lead to the adverse effect described?

Accepted Answer

Amantadine

Answer

Ropinirole

Answer

Tolcapone

Answer

Selegiline

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?